Panagora Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.3M | Sell |
104,935
-38,564
| -27% | -$8.45M | 0.08% | 220 |
|
|
2026
Q1 | $27.1M | Buy |
143,499
+49,697
| +53% | +$8.69M | 0.1% | 191 |
|
|
2025
Q4 | $15.9M | Buy |
93,802
+92,271
| +6,027% | +$14.1M | 0.06% | 240 |
|
|
2025
Q3 | $202K | Sell |
1,531
-85,658
| -98% | -$10.3M | ﹤0.01% | 1095 |
|
|
2025
Q2 | $9.25M | Sell |
87,189
-104
| -0.1% | -$11.3K | 0.04% | 274 |
|
|
2025
Q1 | $10.8M | Buy |
87,293
+85,481
| +4,717% | +$11.2M | 0.05% | 245 |
|
|
2024
Q4 | $223K | Buy |
1,812
+10
| +0.6% | +$1.18K | ﹤0.01% | 1036 |
|
|
2024
Q3 | $201K | Buy |
+1,802
| New | +$197K | ﹤0.01% | 1143 |
|
|
2024
Q2 | – | Sell |
-15,860
| Closed | -$1.91M | – | 1247 |
|
|
2024
Q1 | $1.91M | Sell |
15,860
-2,198
| -12% | -$269K | 0.01% | 591 |
|
|
2023
Q4 | $2.22M | Buy |
18,058
+5,407
| +43% | +$675K | 0.01% | 527 |
|
|
2023
Q3 | $1.64M | Buy |
12,651
+939
| +8% | +$125K | 0.01% | 599 |
|
|
2023
Q2 | $1.45M | Sell |
11,712
-95,062
| -89% | -$12.8M | 0.01% | 665 |
|
|
2023
Q1 | $15.6M | Buy |
106,774
+98,612
| +1,208% | +$14.6M | 0.1% | 188 |
|
|
2022
Q4 | $1.3M | Buy |
8,162
+1,075
| +15% | +$158K | 0.01% | 778 |
|
|
2022
Q3 | $945K | Buy |
7,087
+871
| +14% | +$132K | 0.01% | 877 |
|
|
2022
Q2 | $970K | Sell |
6,216
-37
| -0.6% | -$5.7K | 0.01% | 889 |
|
|
2022
Q1 | $973K | Sell |
6,253
-2,969
| -32% | -$431K | 0.01% | 955 |
|
|
2021
Q4 | $1.18M | Sell |
9,222
-154,162
| -94% | -$20.3M | 0.01% | 843 |
|
|
2021
Q3 | $21.3M | Sell |
163,384
-33,416
| -17% | -$5.05M | 0.11% | 177 |
|
|
2021
Q2 | $35M | Buy |
196,800
+60,547
| +44% | +$10.5M | 0.19% | 123 |
|
|
2021
Q1 | $22.4M | Buy |
136,253
+55,189
| +68% | +$9.08M | 0.13% | 165 |
|
|
2020
Q4 | $13.4M | Buy |
81,064
+64,944
| +403% | +$9.67M | 0.08% | 225 |
|
|
2020
Q3 | $2.3M | Buy |
16,120
+351
| +2% | +$43.5K | 0.01% | 584 |
|
|
2020
Q2 | $1.74M | Buy |
15,769
+1,882
| +14% | +$208K | 0.01% | 720 |
|
|
2020
Q1 | $1.39M | Buy |
13,887
+1,419
| +11% | +$183K | 0.01% | 722 |
|
|
2019
Q4 | $1.86M | Buy |
12,468
+9,543
| +326% | +$1.3M | 0.01% | 813 |
|
|
2019
Q3 | $375K | Buy |
2,925
+1,878
| +179% | +$252K | ﹤0.01% | 1406 |
|
|
2019
Q2 | $149K | Hold |
1,047
| – | – | ﹤0.01% | 1868 |
|
|
2019
Q1 | $150K | Sell |
1,047
-51,886
| -98% | -$6.77M | ﹤0.01% | 1786 |
|
|
2018
Q4 | $6.56M | Buy |
52,933
+52,013
| +5,654% | +$7.72M | 0.03% | 395 |
|
|
2018
Q3 | $155K | Hold |
920
| – | – | ﹤0.01% | 1752 |
|
|
2018
Q2 | $159K | Hold |
920
| – | – | ﹤0.01% | 1725 |
|
|
2018
Q1 | $139K | Sell |
920
-421
| -31% | -$61.8K | ﹤0.01% | 1776 |
|
|
2017
Q4 | $181K | Buy |
1,341
+421
| +46% | +$58.4K | ﹤0.01% | 1706 |
|
|
2017
Q3 | $135K | Hold |
920
| – | – | ﹤0.01% | 1816 |
|
|
2017
Q2 | $143K | Hold |
920
| – | – | ﹤0.01% | 1770 |
|
|
2017
Q1 | $134K | Sell |
920
-6
| -0.6% | -$781 | ﹤0.01% | 1779 |
|
|
2016
Q4 | $101K | Buy |
926
+6
| +0.7% | +$668 | ﹤0.01% | 1944 |
|
|
2016
Q3 | $112K | Hold |
920
| – | – | ﹤0.01% | 1935 |
|
|
2016
Q2 | $130K | Hold |
920
| – | – | ﹤0.01% | 1827 |
|
|
2016
Q1 | $120K | Buy |
+920
| New | +$115K | ﹤0.01% | 1812 |
|
|
2015
Q1 | – | Sell |
-7,305
| Closed | -$1.2M | – | 2363 |
|
|
2014
Q4 | $1.2M | Hold |
7,305
| – | – | 0.01% | 965 |
|
|
2014
Q3 | $1.17M | Sell |
7,305
-45,158
| -86% | -$6.94M | 0.01% | 971 |
|
|
2014
Q2 | $7.71M | Sell |
52,463
-16,241
| -24% | -$2.25M | 0.04% | 410 |
|
|
2014
Q1 | $9.53M | Buy |
68,704
+52,068
| +313% | +$7.84M | 0.05% | 379 |
|
|
2013
Q4 | $2.1M | Hold |
16,636
| – | – | 0.01% | 843 |
|
|
2013
Q3 | $1.53M | Sell |
16,636
-28,886
| -63% | -$2.33M | 0.01% | 920 |
|
|
2013
Q2 | $3.13M | Buy |
+45,522
| New | +$2.78M | 0.02% | 602 |
|
Other funds holding JAZZ
Panagora Asset Management's JAZZ Position: Q2 2026 in Review
Panagora Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q2 2026, selling an estimated $8.45M and leaving 104,935 shares worth $25.3M. The position accounts for 0.08% of the portfolio, ranked #220.
Panagora Asset Management first reported a position in JAZZ in Q2 2013 and has held it in 48 quarters since. The position peaked at $35M in Q2 2021. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Panagora Asset Management held 104,935 shares of Jazz Pharmaceuticals worth $25.3M as of Q2 2026.
- Panagora Asset Management sold 38,564 Jazz Pharmaceuticals shares in Q2 2026, an estimated $8.45M.
- Jazz Pharmaceuticals made up 0.08% of Panagora Asset Management's portfolio in Q2 2026, its #220 holding.
- Panagora Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
- Panagora Asset Management's Jazz Pharmaceuticals position peaked at $35M in Q2 2021.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.